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Sciences, University of Ghana, Accra, GhanaA B S T R A C TObjective: To estimate the wound treatment cost borne by the Buruli
Ulcer Treatment Centre of the Amasaman Government Hospital,
Ghana. Methods: Three different types of data collection approaches
were used, namely, 1) observation checklist, 2) in-depth interviews,
and 3) expenditure data review. Wound dressing processes were
observed. Retrospective health facility cost data of Buruli ulcer (BU)
wound treatment for the year 2011 were used. Cost data gathered
covered medical and nonmedical items. Cost analyses were carried
out to determine the health facility’s ﬁnancial and economic costs.
Results: The total annual ﬁnancial cost was US $121,189.16, of which
99% was recurrent cost. This constitutes about 13% of the expenditure
by the Amasaman Government Hospital for the year 2011. The total
annual economic cost was US $143,609.22, of which 93% was recurrent
cost. The main cost driver for both ﬁnancial and economic costs wasee front matter Copyright & 2014, International S
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of Ghana, Accra, Ghana.personnel. The annual BU wound treatment costs per capita were US
$1615.86 for ﬁnancial cost and US $1914.79 for economic cost,
respectively. The study did not cover household patient costs. Con-
clusions: The cost of BU wound treatment takes a considerable
amount of the hospital’s expenditure. This shows the importance of
health facility cost as one of the decision-making tools for both
resource allocation and mobilization. Hospital management must
therefore constantly examine its stafﬁng norms and the associated
cost to improve the hospital’s resource allocation.
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Buruli ulcer (BU) affects skin, and usually starts as a painless
nodule, papule, plague, or edema. It then commonly advances
into a painless ulcer [1]. But BU can result in severe destruction of
the skin and soft tissues. This leads to the formation of extensive
ulcers, especially on the arms and legs. Affected persons who are
not treated can develop lifelong deformities. Management of BU
is dependent on the stage of the disease. Antibiotics such as
rifampicine and streptomycin are usually used for its manage-
ment. In complicated ulcers, surgery, which may or may not
involve skin grafting, is done [2].
The ﬁrst case of BU in Ghana was reported in 1971 [3,4] and was
brought to public attention in 1993 [5]. Currently, Ghana is the second
most endemic BU country with about 17% of the cases globally [6].
The BU burden has both social and economic dimensions [4]. Studies
have shown that BU has a strong economic burden on the com-
munity and health facilities [7]. In Cameroon, households spend
about 25% of their annual earnings on BU treatment [8] and in Ghana
16% of the households borrow money and 27% sell off their assets as
medical cost for the treatment of BU [4] while health facility cost was
estimated to be about US $80,000 on BU treatment [9].In Ghana, the National Buruli Ulcer Control Programme leads
and coordinates the control of BU. One of the key strategies in
controlling the disease is early detection and treatment [10]. It
has been observed that achievement of this strategy would have
a great effect on the control of the disease in Ghana [11]. Further
development also indicates that African countries affected by the
BU endemic, including Ghana, signed the Cotonou Declaration to
ﬁght BU by several measures including mobilizing additional
resources for its control [12].
Cost data, when available, provide policymakers and manage-
ment an essential and vital tool but are rare in Ghana [13]. Aboagye
et al. [14] also noted that this scarcity in information is because
costing studies are not well established in Ghana and Africa as a
whole. Amofah [13] further explains that this is so because in Ghana,
for example, most health facilities have poor data capturing methods.
Cost have been noted to aid in assessing efﬁciency; provide
indications of cost savings areas; support strategic planning and
budgeting; form an essential ingredient for cost projections and
setting prices; aid in assessing priorities; provide input in design of
ﬁnancing schemes; aid in determining distribution of the cost burden;
and keep track of spending. As Scott et al. [15] observed, however,
economic analysis is based on the fundamental notion of efﬁcient useociety for Pharmacoeconomics and Outcomes Research (ISPOR).
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about resource allocation, and second, efﬁcient use of resources, that
is, getting the most from available resources [15]. Thus, a hospital
administrator, for example, is faced with the challenge of organizing
resources to meet the organization’s goals [15]. But the paucity of cost
data in developing countries suggests that health economic analysis
is not currently being used by a large proportion of the public health
researchers and practitioners, which could in part explain the dearth
of economic analysis that currently exists in the ﬁeld [16].
Wound burden is a new concept [17] and currently gaining
prominence in public health. Chronic wounds are classiﬁed as
wounds that fail to heal within 3 months [18]. The World Alliance
for Wounds and Lymphedema Care recognizes BU as one of the
etiologies of chronic wounds [19]. The worldwide burden of
chronic wounds, however, is not known. But the developed world
has good records of its economic burden [20]. For instance, in
North America, about 6 million chronic wounds occur each year
[12]. Furthermore, chronic wounds are a major health burden and
their management leads to an enormous drain on health care
resources [20–23]. An earlier study in Ghana has also attested to
this fact [9]. According to the National Buruli Ulcer Control
Programme, more than 60% of the new cases detected in early
2008 were in the ulcerative stages [10]. Wound treatment is thus
an essential part of BU case management. Wounds are acknowl-
edged to be a very signiﬁcant source of cost to both the patient and
health care providers [9,24]. Even though wound treatment is a
signiﬁcant source of cost to health facilities, the cost of BU wound
treatment to health facilities in Ghana is not known. This article
estimated the wound treatment cost borne by the Buruli Ulcer
Treatment Centre of the Amasaman Government Hospital, Ghana,
one of the few BU wounds management centers in the country.
Conceptual Framework
Health facility cost of BU wound treatment is made up of
recurrent and capital expenditure. These costs can be further
classiﬁed as ﬁnancial and economic costs. The economic cost
component additionally contains the cost of donated items and
volunteer services. Fig. 1 is a diagrammatic representation of the
conceptual framework for the study.Methods
Study Area
The study was a cross-sectional cost-of-illness study from the
perspective of the health provider. The study was conducted inWound treatment cost
Financial costs:
Recurrent expenditure:
- Personnel
- Medical supplies
- Nonmedical supplies
- Overhead 
Capital expenditure:
- Buildings
- Vehicles
- Equipment
Economic costs:
Recurrent expenditure:
- Personnel (including volunteer 
time)
- Medical supplies (including 
donations) 
- Nonmedical supplies (including 
donations) 
- Overhead items
Capital expenditure:
- Buildings
- Vehicles (including donations)
- Equipment (including donations)
Fig. 1 – Health facility cost of BU wound treatment. BU,
Buruli ulcer.the Amasaman Government Hospital of the Ga West Municipal-
ity, Greater Accra Region, Ghana, with the main hospital having
a 106-bed capacity. The Amasaman Government Hospital serves
as the main municipal hospital and a referral center for the other
nine government health facilities in the municipality. In addi-
tion, the hospital is one of the BU treatment centers in Ghana,
with a BU ward bed capacity of 34. Patients with ulcers are
admitted in the ward for daily wound treatment. The Ga West
Municipality is ranked ﬁfth in BU endemic areas in Ghana, with a
prevalence of about 87.7 per 100,000 persons [4]. The municipal-
ity also has the highest number of healed and active lesions
of BU countrywide [25]. The study focused on the Buruli Ulcer
Treatment Centre.
Data Collection Methods
Observation checklist
A structured observation checklist was used to assess the process
of wound dressing. The information collected included the
categories and number of medical staff involved in the wound
dressing, the type of wound cleaning/dressing agents/solutions
used, and the types and numbers of instruments used in the
wound dressing.
In-depth interviews
In-depth interviews were held with 1) the nurse in charge of the
BU ward, 2) the hospital administrator, and 3) the hospital
accountant. The interview guide covered the following areas:
type of staff, staff strength of the BU ward, management of the
BU ward, hospital’s overhead costs, funding sources, donations,
and types and number of volunteers who work in the BU ward.
Expenditure data review
Retrospective health facility cost data for the treatment of wounds
of patients with BU for the year 2011 were used. The sources of
data were the Hospital’s Accounts Department, the Stores, and
the Electricity Company of Ghana, Amasaman. The recurrent
items covered personnel, that is, staff and volunteers, utilities,
that is, water and electricity, maintenance, medical supplies and
consumables, and nonmedical supplies, that is, stationary, bed,
and food supplied. The capital items were building/space,
vehicles, medical devices, that is, surgical instruments, stetho-
scopes, and wound dressing instruments, and nonmedical devi-
ces, that is, furniture, televisions, and air conditioners. The
replacement costs were used to value items whose prices were
not readily available. Floor spaces of the BU ward, that is, surgical
and nonsurgical, BU ward kitchen, and Central Sterile Supply
Department were measured and valued using the standard
Municipal Land Valuation Department cost per square meter.
With the assistance of the Hospital’s Accounts Department,
shared-out ratios for the allocation of joint/share costs were
determined.
Data Analysis
All cost data were entered and analyzed in Microsoft Excel, 2010
edition.
Financial cost analysis
The ﬁnancial capital cost estimation of vehicles and medical and
nonmedical devices was based on their quantities multiplied by
their replacement costs and divided by the respective working or
useful lives of the products. Building cost was obtained by
multiplying the total estimated space by the standard Municipal
Land Valuation Department cost per square meter. Then, a
predetermined share-out ratio was applied to vehicles (4%),
Table 1 – Estimation of cost share-out ratios used.
No. Cost component Estimation
1 Personnel Calculated as a percentage of the
number of days worked by staff
in the BU ward in a month. BU
staff worked 20 of the 28 days in
a month in the BU ward, giving
71%. This was obtained from in-
depth interviews.
2 Management Calculated as a percentage of the
number of management
meetings held in a month.
Management meetings were
held once in a month. Therefore,
1 by 28 days gives 4%. This was
obtained from in-depth
interviews.
3 Wound medical
supplies/
consumables
All supplies in the BU ward were
for wound treatment. Thus,
100%. This was obtained from
expenditure records.
4 Vehicle
maintenance
Expenditure records show that 4%
of the hospital’s vehicle cost was
allocated to the BU ward. The
same proportion was used for
the vehicle maintenance.
5 Building
maintenance
The share-out ratio was crudely
estimated from the number of
buildings in the hospital. There
were a total of 20 buildings, of
which 3 were used for BU
activities. Thus, the same
proportion of 15% was allocated
to the BU ward. This was
obtained from in-depth
interviews.
6 Water supplies This was calculated as a
percentage of water storage
points in the hospital. There
were 22 water storage points, of
which 3 were dedicated to the
BU ward. This represents 14%.
This was obtained from in-depth
interviews.
7 Laundry The estimate was based on the
laundry days in the hospital.
The Hospitals’ Laundry
Department does the laundry of
the BU ward once a month, i.e., 1
of 28 days. Thus, 5% of the
laundry cost was allocated to BU
wound care. This was obtained
from in-depth interviews.
8 Sterilization This was based on the Central
Sterile Supply Department
(CSSD) of the hospital’s weekly
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priate costs to BU. The total ﬁnancial capital cost was obtained by
summing up the individual capital costs estimated. The ﬁnancial
recurrent cost covered the recurrent items. Personnel costs were
obtained by multiplying the types and numbers of various staff
by their respective annual gross emolument or valued work in
the case of volunteers. The medical and nonmedical supplies/
consumables/services cost was obtained by summing all the
quantities used in the year and multiplying them by their
individual costs or replacement costs. Table 1 summarizes the
share-out ratio estimation approach used. The individual recur-
rent costs were summed up to obtain the total ﬁnancial recurrent
cost. Finally, the total ﬁnancial recurrent and total ﬁnancial
capital costs were summed up as the estimated total annual
ﬁnancial cost of BU wound treatment.
Economic cost analysis
The economic capital costs of vehicles and medical and non-
medical devices including all donated items were based on the
annualization of their respective costs using their useful lives and
a discount rate of 3% [26] to determine each item’s discounting
factor. The product of the item’s replacement cost and quantities
used was divided by their discounting factor to obtain their
annualized costs. The sum total of all the annualized item costs
was the total annual economic capital cost. The estimation of the
recurrent cost was similar to that of the ﬁnancial cost estimation;
however, economic cost included the cost of donated items and
the cost of cost volunteers. The same share-out ratios in Table 1
were used to apportion cost in the economic analysis. Finally, the
total annual economic recurrent and total economic capital costs
were summed up to obtain the estimated total annual economic
cost of BU wound treatment.
Assumptions
In both ﬁnancial and economic analyses, the following assump-
tions were made: 1) the medical consumables and drugs supplied
to the BU ward in 2011 were used by the patients with BU alone;
2) building maintenance and water costs were assumed to be the
same for all wards in the hospital; and 3) all other resources
allocated to the BU ward were used mainly for wound treatment,
which was the main reason for hospitalization in the ward.
Sensitivity Analysis
Sensitivity analysis to test the robustness of the estimated
annual ﬁnancial and economic costs was conducted. The param-
eters used were as follows: 1) discount rate (5%–10%); 2) variation
in vehicle cost allocated to the BU ward (5%–10%); and 3) variation
in BU ward staff salaries and beneﬁts (increased by 20%–50%).
Ethical consideration
Before data collection, ethical clearance was obtained from the
Ethical Review Committee, Research and Development Division,
Ghana Health Services, Ghana. Approval for the study was also
obtained from the Municipal Director of Health Services and the
management of the Amasaman Government Hospital.sterilization schedule. The BU
materials were sterilized three
times in a week; thus, 43% of the
cost of CSSD was allocated to BU
wound care. This was obtained
from in-depth interviews.
BU, Buruli ulcer.Results
Annual Financial Costs of BU Wound Treatment
Table 2 presents the annual ﬁnancial and economic costs of BU
wound treatment. The total annual ﬁnancial cost was US
$121,189.16, of which 99% was recurrent cost. This cost also
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Government Hospital for the year 2011.
The main recurrent cost drivers were personnel (73%) and
medical supplies and consumables (11%) in total to account for
84% of the ﬁnancial cost. The rest of the items in total accounted
for 16% of the total ﬁnancial cost. The annual BU ﬁnancial wound
treatment cost per capita was US $1615.86.
Annual Economic Costs of BU Wound Treatment
The total annual economic cost was US $143,609.22, of which 93%
was recurrent cost and 7% was capital cost. The main cost driver
in the economic cost again was personnel (70%). The rest of the
items in the total economic cost accounted for 30% of the total
economic cost. Overall, differences in cost proﬁles of ﬁnancial and
economic costs were the valuations of donations and volunteer
times, which was taken into consideration in the case of economic
cost. The annual BU economic wound treatment cost per capita
was US $1914.79. Sensitivity analyses showed a signiﬁcant differ-
ence in recurrent and capital costs of both ﬁnancial and economic
costs, with about 33% increase in ﬁnancial costs.Discussion
In sum, the total annual ﬁnancial and economic cost was US
$121,189 and US $143,609, respectively, with the main cost driver
in both cases being personnel. Furthermore, annual BU wound
treatment costs per capita were US $1616 for ﬁnancial cost and
US$1915 for economic cost. This provides a considerably high
cost per patient. Other studies have also shown that wound
treatment cost is signiﬁcant [20]. For instance, studies in the
United Kingdom [20,22], in the United States [21,23], and then in
Ghana [9] have all attested to this high cost of wound treatment.
The cost proﬁles of most of these studies show that recurrent
costs constituted a large proportion of the cost as has also been
shown in this study. Of this recurrent expenditure, personnel
cost has been shown to be most signiﬁcant in most studies [14,27]
(T. Tsilaajav, unpublished data, 2009). Dressing materials cost has
also been found to be considerable [24]. The World Health
Organization has observed that these costs can be reduced in
the case of BU by early detection and treatment (i.e., preulcerative
stages) [28]. It further suggests that the average cost of treating
BU disease in 1994-1996 was about US $780. This study showsTable 2 – Annual health facility ﬁnancial and economic c
Items Type of resources Financia
(US $
Capital items Buildings/space 54
Vehicle 254
Medical devices 605
Nonmedical devices 142
Subtotal 1,057
Recurrent items Personnel 88,334
Utilities 4,139
Maintenance 8,603
Medical supplies & consumables 13,379
Nonmedical supplies 3,082
Bed & feeding 2,592
Subtotal 120,131
Total cost 121,189
Currency conversion rate: US $1 ¼ Ghana cedis (GH⊄) 1.62.that currently the estimated cost of BU wound treatment ranges
from US $1616 to US $1915. This increase in BU wound treatment
cost may be due to medical inﬂation, primarily from the sub-
stantial increase in staff remuneration over the period. Other
contributory factors are general inﬂation of goods and services
and introduction of new treatment therapies in the past decade
between the two studies.
As Macdonald and Asiedu [20] indicated, however, “global-
ization of modern wound and lymphedema management is
beginning to take a giant step” [20]. They are hopeful that
continuous “spread of knowledge of the basic principles of
wound and lymphedema management, application techniques,
and the teamwork of both national and international medical
teams” will be the panacea to wound treatment. But all these
proposals have resource allocation and mobilization implica-
tions, and thus especially developing countries need to start
gathering some cost data to inform these decisions.
Our ﬁndings have shown that wound treatment is costly and
labor intensive. The sensitivity analysis also indicates that
changes in staff remunerations substantially increase the cost.
The hospital management should take a critical look at issues of
resource allocation and efﬁciency. One way of improving
resource allocation is for the management to introduce compre-
hensive wound care management training for all nursing
staff not only to improve their skills but also to make staff
rotations easier and minimize wastage. As other studies [5,25]
in Ghana show that reported BU cases at modern health facilities
are usually late and bad ulcers, wound treatment will continu-
ously form an important integral part of BU case management,
which has already been noted to be labor intensive; this may
invariably affect staff utilization elsewhere in the hospital,
resulting in acute shortages in some departments. Hospital
management must therefore constantly examine its stafﬁng
norms and its associated cost to improve the hospital’s resource
allocation.
As most developing countries strive to institute universal
coverage of health services, which implies a change in service
payment systems, having the requisite cost data to justify the
resources necessary to allow facilities to continue to care for the
most highly wound burdened patient will become increasingly
important [17]. Health managers are therefore entreated to
undertake periodic assessment of cost-of-services provision in
their respective facilities to inform policy and management
decisions [13].osts of Buruli ulcer wound treatment.
l cost
)
Cost proﬁle
(%)
Economic cost
(US $)
Cost proﬁle
(%)
.01 – 6,040.90 4
.86 – 278.25 –
.67 – 3,067.57 2
.85 – 633.88 –
.38 1 10,020.60 7
.02 73 100,957.84 70
.53 3 4,139.53 3
.96 7 8,603.96 6
.16 11 13,379.16 9
.51 3 3,082.51 2
.59 2 3,425.62 2
.78 99 133,588.62 93
.16 100 143,609.22 100
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The cost of BU wound treatment makes a considerable amount of
the hospitals’ expenditure. This shows the importance of cost as
one of the decision-making input to be used for both resource
allocation and mobilization. Hospitals’ management must there-
fore constantly examine their stafﬁng norms and the associated
cost to improve the hospitals’ resource allocation.Acknowledgments
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